alizarin red s has been researched along with Osteogenic Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berreur, M; Blanchard, F; Chipoy, C; Colombeix, C; Couillaud, S; Heymann, D; Pradal, G; RĂ©dini, F; Vallette, F | 1 |
1 other study(ies) available for alizarin red s and Osteogenic Sarcoma
Article | Year |
---|---|
Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
Topics: Alkaline Phosphatase; Animals; Anthraquinones; Blotting, Western; Bone and Bones; Bone Marrow Cells; Butadienes; Cell Cycle Proteins; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; DNA; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Immunohistochemistry; Inflammation; Integrin-Binding Sialoprotein; Interleukin-6; Mesoderm; Microscopy, Confocal; Microscopy, Electron; Models, Biological; Nitriles; Osteoblasts; Osteocalcin; Osteosarcoma; Protein Kinase C; Protein Kinase C-delta; Rats; Regeneration; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sialoglycoproteins; Signal Transduction; STAT3 Transcription Factor; Stem Cells; Thymidine; Time Factors; Trans-Activators; Transfection | 2004 |